- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diagnostic Nerve Block in Canada
Total 791 results
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditionsCanada
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingCancer Survivor | Retinoblastoma | Unilateral Retinoblastoma | Intraocular Retinoblastoma | Biological SiblingUnited States, Canada
-
Grupo Espanol de Tumores NeuroendocrinosPfizer; Threshold PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine TumorsSpain
-
University of LouisvilleNational Institute on Aging (NIA)CompletedProgressive Supranuclear PalsyUnited States, Canada
-
ExelixisCompletedAstrocytic TumorsUnited States, Canada
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingGlioblastomaUnited States, Germany, Spain, Belgium, Italy, Australia, Canada, France, Poland
-
Boehringer IngelheimCompletedGliomaUnited States, Canada
-
British Columbia Cancer AgencyBC Cancer FoundationCompletedGastrointestinal Stromal Tumors | Colorectal Cancer Metastatic | Advanced Melanoma | Advanced Non-Small Cell Lung Carcinoma | Patients With Diagnosed Malignancies Being Considered for Clinical TrialsCanada
-
Grupo Español Multidisciplinar de MelanomaBristol-Myers SquibbCompleted
-
IpsenTerminatedNeuroendocrine Tumors in LungCanada, United States, Germany, France, United Kingdom, Netherlands, Spain, Denmark, Italy, Austria, Poland
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
Donald MabbottRecruitingCognitive Impairment | Medulloblastoma, ChildhoodCanada, Australia
-
Daiichi Sankyo, Inc.Completed
-
Novartis PharmaceuticalsCompletedRecurrent Glioblastoma MultiformeUnited States, Belgium, Australia, Spain, France, Canada
-
Giselle ShollerBeat NB Cancer Foundation; K C Pharmaceuticals Inc.; Team Parker for Life; Dell...RecruitingNeuroblastomaUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingProgressive Supranuclear Palsy (PSP)Germany, United Kingdom, Canada, United States
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
Bristol-Myers SquibbCompletedMelanomaFrance, Canada, United States, Germany, Australia, Russian Federation, Spain, Italy, Netherlands, Poland, Denmark, Israel, United Kingdom
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingMedulloblastomaUnited States, Canada, Australia, New Zealand
-
Melanoma and Skin Cancer Trials LimitedNorfolk and Norwich University Hospitals NHS Foundation Trust; Peter MacCallum...Active, not recruitingCutaneous Melanoma by AJCC V7 StageUnited Kingdom, United States, Sweden, Australia, Canada
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis 1 | Plexiform Neurofibroma (PN)United States, Canada, France, Italy, Germany, China, United Kingdom, Spain, Japan, Russian Federation, Australia, Poland, Brazil
-
Giselle ShollerBeat NB Cancer Foundation; K C Pharmaceuticals Inc.; Team Parker for LifeRecruitingNeuroblastomaUnited States, Canada
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Instil BioTerminatedAdvanced Cutaneous MelanomaUnited States, Canada, United Kingdom
-
PfizerCompletedMelanomaUnited States, Australia, Canada, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinomatous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
National Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Pancreatic Neoplasm | Stage III Pancreatic Neuroendocrine Tumor AJCC v8 | Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 | Unresectable Pancreatic Neuroendocrine TumorUnited States, Canada
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
Camurus ABActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorUnited States, Belgium, Spain, Netherlands, France, Germany, Israel, Italy, Canada, Australia, Romania, Hungary
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Jennerex BiotherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Lung Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
MedImmune LLCCompletedNeuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersUnited States, Czechia, Thailand, Germany, Korea, Republic of, Israel, New Zealand, Spain, Taiwan, Japan, Turkey, Hungary, Bulgaria, Mexico, Russian Federation, Colombia, Peru, Poland, Estonia, South Africa, Canada, Australia, Hong... and more
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory NeuroblastomaUnited States, Canada
-
AstraZenecaActive, not recruitingMelanomaFrance, Germany, Italy, Spain, Belgium, Canada, Poland, Korea, Republic of, United Kingdom, United States, Australia
-
Hoffmann-La RocheCompletedHigh Grade GliomaUnited Kingdom, Canada, Austria, Italy, Spain, Sweden, Belgium, Denmark, France, Australia, Czechia, Hungary, Netherlands, Poland
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Apexigen America, Inc.TerminatedMelanoma | Cancer | Metastatic Melanoma | Melanoma (Skin) | Unresectable Melanoma | Cancer of SkinSpain, Poland
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; University of Colorado... and other collaboratorsCompleted
-
Philogen S.p.A.RecruitingMelanoma Stage IIIB/CSpain, United States, Switzerland